Thyroid cancer stem cells

Nature Reviews Endocrinology

Volumn 7, Issue 10, 2011, Pages 609-616

  Lin, Reigh Yi ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; METASTASIS; PRIORITY JOURNAL; REVIEW; THYROID CANCER;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEOPLASTIC STEM CELLS; STEM CELL NICHE; THYROID NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 80053156155     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.127     Document Type: Review

References (58)

1. Davies, L. & Welch, H. G. Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295, 2164-2167 (2006).
2. American Cancer Society. Cancer Facts & Figures 2010 American Cancer Society [online], http://www.cancer.org/Research/CancerFactsFigures/ CancerFactsFigures/cancer facts and figures 2010 (2010).
3. Takano, T. & Amino, N. Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid 15, 432-438 (2005). (Pubitemid 40770622)
4. Todaro, M. et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res. 70, 8874-8885 (2010).
5. Pitman, K. T., Johnson, J. T. & Myers, E. N. Papillary thyroid carcinoma associated with squamous cell carcinoma of the head and neck: significance and treatment. Am. J. Otolaryngol. 17, 190-196 (1996). (Pubitemid 26152135)
6. Randolph, G. W., Thompson, G. B., Branovan, D. I. & Tuttle, R. M. Treatment of thyroid cancer: 2007-a basic review. Int. J. Radiat. Oncol. Biol. Phys. 69, S92-S97 (2007). (Pubitemid 47376847)
7. Vasko, V., Bauer, A. J., Tuttle, R. M. & Francis, G. L. Papillary and follicular thyroid cancers in children. Endocr. Dev. 10, 140-172 (2007).
8. Caron, N. R. & Clark, O. H. Papillary thyroid cancer. Curr. Treat. Options Oncol. 7, 309-319 (2006). (Pubitemid 44043660)
9. Emerick, G. T., Duh, Q. Y., Siperstein, A. E., Burrow, G. N. & Clark, O. H. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 72, 3287-3295 (1993). (Pubitemid 23356775)
10. Simpson, W. J. et al. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am. J. Med. 83, 479-488 (1987).
11. de Groot, J. W. et al. Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clin. Endocrinol. (Oxf.) 65, 729-736 (2006). (Pubitemid 44772352)
12. Takahashi, C. & Ewen, M. E. Genetic interaction between Rb and N ras: differentiation control and metastasis. Cancer Res. 66, 9345-9348 (2006). (Pubitemid 44623626)
13. Al-Rawi, M. & Wheeler, M. H. Medullary thyroid carcinoma update and present management controversies. Ann. R. Coll. Surg. Engl. 88, 433-438 (2006). (Pubitemid 44390349)
14. Simpson, W. J. Anaplastic thyroid carcinoma: a new approach. Can. J. Surg. 23, 25-27 (1980). (Pubitemid 10159897)
15. Tan, R. K. et al. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 17, 41-48 (1995).
16. Staunton, M. D. Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival. Eur. J. Surg. Oncol. 20, 613-621 (1994).
17. Ain, K. B. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin. Surg. Oncol. 16, 64-69 (1999).
18. Kondo, T., Ezzat, S. & Asa, S. L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer 6, 292-306 (2006).
19. Venkatesh, Y. S. et al. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66, 321-330 (1990). (Pubitemid 20205915)
20. McIver, B. et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130, 1028-1034 (2001). (Pubitemid 34014569)
21. Dumont, J. E., Lamy, F., Roger, P. & Maenhaut, C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72, 667-697 (1992).
22. Nikiforova, M. N. et al. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett. 209, 1-6 (2004). (Pubitemid 38656111)
23. Takano, T. Fetal cell carcinogenesis of the thyroid: theory and practice. Semin. Cancer Biol. 17, 233-240 (2007). (Pubitemid 46413073)
24. Nikiforov, Y. & Gnepp, D. R. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 74, 748-766 (1994). (Pubitemid 24217643)
25. Jhiang, S. M. et al. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137, 375-378 (1996). (Pubitemid 26005013)
26. Portella, G. et al. Human N ras, TRK T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells. Oncol. Res. 11, 421-427 (1999).
27. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737 (1997). (Pubitemid 27298715)
28. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. & Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951 (2005). (Pubitemid 41713363)
29. Wang, X. et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461, 495-500 (2009).
30. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003). (Pubitemid 36418143)
31. Zhu, L. et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603-607 (2009).
32. Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003). (Pubitemid 37187480)
33. Ricci-Vitiani, L. et al. Identification and expansion of human colon cancer initiating cells. Nature 445, 111-115 (2007). (Pubitemid 46067311)
34. Monzani, E. et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer 43, 935-946 (2007). (Pubitemid 46366698)
35. Klein, W. M. et al. Increased expression of stem cell markers in malignant melanoma. Mod. Pathol. 20, 102-107 (2007). (Pubitemid 44967955)
36. Dou, J. et al. Isolation and identification of cancer stem-like cells from murine melanoma cell lines. Cell. Mol. Immunol. 4, 467-472 (2007).
37. Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593-598 (2008).
38. Schatton, T. et al. Identification of cells initiating melanomas. Nature 451, 345-349 (2008).
39. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004). (Pubitemid 39551674)
40. Shu, Q. et al. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells 26, 1414-1424 (2008).
41. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007). (Pubitemid 46067310)
42. Miki, J. et al. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 67, 3153-3161 (2007). (Pubitemid 46724852)
43. Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323 (2007). (Pubitemid 47355323)
44. Beier, D. et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010-4015 (2007). (Pubitemid 46815044)
45. Zito, G. et al. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS ONE 3, e3544 (2008).
46. Friedman, S., Lu, M., Schultz, A., Thomas, D. & Lin, R. Y. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS ONE 4, e5395 (2009).
47. Schweppe, R. E. et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J. Clin. Endocrinol. Metab. 93, 4331-4341 (2008). (Pubitemid 352789529)
48. Hoshi, N., Kusakabe, T., Taylor, B. J. & Kimura, S. Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology 148, 4251-4258 (2007). (Pubitemid 47295711)
49. Lan, L., Cui, D., Nowka, K. & Derwahl, M. Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require TSH for differentiation into thyrocytes. J. Clin. Endocrinol. Metab. 92, 3681-3688 (2007). (Pubitemid 47435356)
50. Mitsutake, N. et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148, 1797-1803 (2007). (Pubitemid 46457095)
51. Sullivan, P. et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 70, 9937-9948 (2010).
52. Croker, A. K. et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J. Cell. Mol. Med. 13, 2236-2252 (2009).
53. Shmelkov, S. V. et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J. Clin. Invest. 118, 2111-2120 (2008). (Pubitemid 351872330)
54. Malaguarnera, R. et al. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J. Clin. Endocrinol. Metab. 96, 766-774 (2011).
55. Derwahl, M. Linking stem cells to thyroid cancer. J. Clin. Endocrinol. Metab. 96, 610-613 (2011).
56. Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315-1321 (2007). (Pubitemid 350076512)
57. Zheng, X., Cui, D., Xu, S., Brabant, G. & Derwahl, M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int. J. Oncol. 37, 307-315 (2010).
58. Beier, D. et al. CD133 Expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol. 18, 370-377 (2008). (Pubitemid 351782845)